On November 5, 2025, Suzhou Fengbei Biotechnology Co., Ltd. (stock code: 603334, “Fengbei Bio”) was successfully listed on the Main Board of the Shanghai Stock Exchange. Fengbei Bio issued 35.9 million shares in this offering, priced at CNY 24.49 per share, with total proceeds expected to reach approximately CNY 879.19 million.

Fengbei Bio is a high-tech enterprise focused on the comprehensive utilization of waste resources. The company has long been dedicated to efficient recycling and reuse of waste oil and grease. Through continuous R&D and industrial practice, Fengbei Bio has expanded both the scope and depth of its integrated waste oil utilization business, establishing a closed-loop industrial chain of “waste oil – biofuel (biodiesel) – bio-based materials”. In addition, leveraging its core technological strengths and channel advantages in oil recycling, the company actively provides customized oleochemical services to clients.

Fengbei Bio’s main products are biofuels and bio-based materials. The company uses its own proprietary technologies to comprehensively utilize waste oils and grease. These technologies enable Fengbei Bio to process a wide range of waste oil sources by purifying, converting, and separating complex components from various collection channels. It also helps the company find new uses for these recycled products, such as agrochemicals. The IPO will help the company grow its production and strengthen its role across the entire waste recycling chain.

Fangda acted as the issuer’s legal counsel throughout Fengbei Bio’s listing on the Main Board of the Shanghai Stock Exchange. The transaction was led by partners Aaron CHEN and Jane CHEN. The team included counsel WANG Yusong.